Skip to main content

EUROpean clinical validation of a new ex vivo eXpanded stem cell theraPy for cArdiac regeNeration after acute myocarDial infarction: EUROXPAND

Project description

An ex vivo cell expansion therapy for heart attack

Call for proposal

H2020-SMEInst-2016-2017

See other projects for this call

Sub call

H2020-SMEINST-2-2016-2017

Coordinator

CELLPROTHERA
Net EU contribution
€ 5 000 000,00
Address
12 Rue Du Parc
68100 Mulhouse
France

See on map

Region
Grand Est Alsace Haut-Rhin
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 0,00